Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

IVD Reagent Development Platform at Creative Biolabs Provides Support in Fight Against COVID-19

To boost COVID-19 research, Creative Biolabs has updated in vitro diagnostic (IVD) reagent development platform covering molecular diagnostics development services, SARS-CoV-2 detection kits for veterinary use, and SARS-CoV-2 antibody or antigen detection kits.

New York, United States - August 30, 2021 /MarketersMedia/

The COVID-19 pandemic, continuing to spread around the world, is likely to be the most devastating in the last 100 years after the Spanish flu, as the official global death toll has topped 4 million in July. The epidemic necessitates a rapid assessment of multiple approaches for scientists all around the world to look for answers in diagnostics, medicines and vaccines to combat SARS-CoV-2.

As a member of the scientific community, Creative Biolabs moves fast to the fight against COVID-19 by providing CRO services regarding to anti-SARS-COV-2 vaccine as well as drug development services. Recently, the expert team has optimized in vitro diagnostic (IVD) reagent development platform for improved detection and control of SARS-CoV-2.

Creative Biolabs provides molecular diagnostics development services for SARS-CoV-2 detection to international clients. From the development and validation of molecular diagnostic test systems through the transfer into new ready-to-use IVD kits, the services cover the whole process with the support of experienced scientific teams and a collection of assay platforms including RT-PCR, rRT-pcr, RT-LAMP, and RNA imaging.

SARS-CoV-2 has been found in more than 10 different animal species. Therefore, evaluating the susceptibility of various species, as well as whether they can infect other animals, is an integral part of the antiviral research. Creative Biolabs has developed Anti-Nucleocapsid Antibody ELISA Kit (Cat. VCok-Wyb037) that can detect the level of anti-SARS-CoV-2 nucleocapsid antibodies in the serum or plasma of various species of animals, such as cats, dogs, cattle, sheep, goats, and horses.

Other CE confirmed SARS-CoV-2 detection kits based on colloidal gold immunochromatography or ELISA are also available:

· COVID-19 IgM/IgG Antibody Test Kit (Colloidal Gold Immunochromatography)
· SARS-CoV-2 Antigen ELISA Kit
* The products are for research use only.

In addition to the latest virus detection kits, Creative Biolabs has successfully developed and produced a series of related products, covering recombinant proteins, antibodies, plasmids, aptamers, pseudovirus, animal model, and cell lines for SARS-CoV-2. More information can be found on

About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs has successfully accomplished numerous challenging projects for customers in requirements with accumulated experience in drug discovery and vaccine development. Especially in the field of SARS-CoV-2 antiviral drugs and vaccines, Creative Biolabs provides drug discovery, vaccine design, preclinical evaluation of drugs and vaccines, and in vitro diagnostic services at the world-leading level.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs

Source URL:

Source: MarketersMedia

Release ID: 89043431

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.